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Rosette formation in 154 fresh Plasmodium falciparum isolates from Kenyan children with mild (n 5 54),
moderate (n 5 64), or severe (n 5 36) malaria was studied to determine whether the ability to form rosettes
in vitro is correlated with malaria severity. There was a wide distribution of rosette frequencies within each
clinical category; however, a clear trend towards higher rosette frequency with increasing severity of disease
was seen, with the median rosette frequency of the mild-malaria group (1%; range, 0 to 82%) being significantly
lower than those of the moderate-malaria group (5%; range, 0 to 45%; Mann-Whitney U test, P< 0.02) and the
severe-malaria group (7%; range, 0 to 97%; Mann-Whitney U test, P < 0.003). Within the severe-malaria
category there was no difference in rosetting among isolates from cerebral malaria patients or those with other
forms of severe malaria. We also examined the ABO blood groups of the patients from whom isolates were
obtained and found that isolates from group O patients (median rosette frequency, 2%; range 0 to 45%)
rosetted less well than those from group A (median, 7%; range 0 to 82%; Mann-Whitney U test, P < 0.01) or
group AB (median, 11%; range 0 to 94%; Mann-Whitney U test, P < 0.03). We therefore confirm that rosetting
is associated with severe malaria and provide further evidence that rosetting is influenced by ABO blood group
type. Whether rosetting itself plays a direct role in the pathogenesis of severe malaria or is a marker for some
other causal factor remains unknown.
Plasmodium falciparum malaria remains a common cause of
morbidity and mortality throughout the tropical regions of the
world and is estimated to cause 1 million deaths a year in
Africa alone (6). Although infection with malaria parasites is
common, only 1 to 2% of infections lead to severe life-threat-
ening disease characterized by a range of clinical features,
including unrousable coma (cerebral malaria), severe anemia,
metabolic acidosis, and multiorgan failure (25). The majority
of malarial deaths in Africa occur in children under 5 years of
age, as with increasing age and recurrent exposure to malaria
a nonsterile immunity develops (14). It remains unclear why
some children develop the severe manifestations of disease
while others suffer only mild symptoms or remain asymptom-
atic.
The pathogenesis of malaria is incompletely understood, but
severe disease is thought to be related to the sequestration of
parasitized erythrocytes in vascular beds within the brain and
other vital organs (13). Sequestration occurs by means of cy-
toadherence to endothelial cells, and several receptors have
been identified which may mediate this interaction, including
CD36 (18), thrombospondin (22), the intercellular adhesion
molecule 1 (2), the vascular cell adhesion molecule, and E-
selectin (17). It remains unclear how and if adhesion to any of
these receptors is related to the development of severe ma-
laria, as studies with field isolates have to date been inconclu-
sive (10, 15, 16).
Another adhesion property demonstrated by some P. falci-
parum isolates which has been associated with severe malaria is
rosette formation. Rosetting is the spontaneous binding of
uninfected erythrocytes to erythrocytes infected with mature
asexual parasites (5). Two studies in The Gambia have shown
that parasite isolates from children with cerebral malaria have
a higher mean rosette frequency than those from children with
mild malaria and that children with cerebral malaria are less
likely to have rosette-disrupting antibodies, suggesting that
rosetting may contribute to the pathogenesis of cerebral ma-
laria (3, 23). A subsequent study of Thai adults showed a
higher median rosette frequency in isolates from cerebral cases
than in isolates from other severe malarias and nonsevere
controls; however, the numbers in this study were small and the
differences were not statistically significant (9). Another small
study in Madagascar showed that the median rosette frequen-
cies were higher in cases of cerebral and other severe malarias
than in cases of uncomplicated malaria (21).
We therefore examined rosetting in 154 isolates from pa-
tients in Kenya with severe, moderate, and mild malaria to see
if rosetting was associated with disease severity in East Africa
and to determine whether rosetting was specifically associated
with cerebral malaria or whether it was also seen with other
forms of severe malaria.
MATERIALS AND METHODS
Patients. Blood samples from children with a parasitemia level of 0.3% or
higher were collected at Kilifi District Hospital, Kilifi, Kenya. Three groups of
children were studied: those with mild, moderate, and severe malaria. Children
with mild malaria exhibited an acute febrile illness but no features of severe
malaria and were treated as outpatients. Children with moderate malaria were
admitted to the pediatric ward but did not fulfill the criteria for admission to the
high-dependency unit (i.e., they showed no disturbance of consciousness, they
were not prostrated [unable to maintain a sitting posture], and they did not have
respiratory distress). All children from the mild malaria and moderate malaria
groups made an uneventful recovery on oral therapy. Children with severe
malaria were admitted to the high-dependency unit for parenteral therapy. These
fell into two broad groups: (i) those with cerebral malaria (i.e., children in a coma
and unable to localize a painful stimulus) and (ii) fully conscious children who
were either prostrated or in respiratory distress (having abnormally deep breath-
ing with intercostal or subcostal recession). The majority of the latter group were
severely anemic (hemoglobin level,,5 g/dl), severely acidotic (bicarbonate level,
,15 mmol/liter), or both.
Parasite culture. One-milliliter blood samples were collected into 0.15 ml of
acid-citrate-dextrose. It has been shown previously that the type of anticoagulant
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used to collect samples (acid-citrate-dextrose or heparin) did not influence the
final rosette frequency (22a). Isolates were spun through Lymphoprep, washed
twice to remove leukocytes, and then cultured by standard methods with RPMI
medium supplemented with 25 mM glucose, 37.5 mM HEPES (N-2-hydroxyeth-
ylpiperazine-N9-2-ethanesulfonic acid), 2 mM glutamine, 25 mg of gentamicin
per ml, and 10% human AB serum, with the pH of the final solution adjusted to
between 7.2 and 7.4 with 1 MNaOH. Cultures were gassed with a mixture of 94%
nitrogen, 5% carbon dioxide, and 1% oxygen. Parasites were grown for at least
16 h in vitro, and maturity was assessed with Giemsa-stained thin films.
Assessment of rosette frequency. Rosette frequency was assessed when the
majority of parasites in a culture had reached the pigmented trophozoite or
schizont stage. Of 184 isolates, 154 grew to maturity. Of the 30 isolates which
failed to grow, 9 were from severe cases, 14 were from moderate cases, and 7
were from mild cases. To assess rosette frequency a sample of parasite culture at
1 to 2% hematocrit was stained with 20 mg of ethidium bromide per ml, and a wet
preparation of the culture was viewed under fluorescence. Two hundred cells
infected with mature parasites were counted, with the binding of two or more
uninfected erythrocytes constituting a rosette. The rosette frequency is the per-
centage of mature-parasite-infected cells found in rosettes. Assessment of rosette
frequency was made without knowledge of the clinical category of all samples.
Assessment of antirosetting antibodies. Isolates with rosette frequencies of
.20% were tested with plasma from the same patient for the presence of
rosette-disrupting antibodies. One hundred microliters of parasite culture was
incubated for 30 min at 378C at a final plasma dilution of 1/5 before the assess-
ment of rosette frequency and was compared with a control incubated with a 1/5
dilution of European AB plasma. Plasma samples from all patients were stored
at 2208C and transported to the United Kingdom, where they were later tested
at a 1/10 dilution for their ability to disrupt a laboratory rosetting clone, R29, and
compared with a European plasma control. R29 has a baseline rosette frequency
of 50 to 80%.
Blood grouping. The patient’s ABO blood group was determined for each
isolate by a standard slide agglutination technique.
Statistics. Correlations were assessed by the method of least squares, and
medians were compared by the Mann-Whitney U test.
RESULTS
Isolates which grew to maturity were obtained from 54 mild,
64 moderate, and 36 severe malaria cases. The characteristics
of the three groups are shown in Table 1. There was no cor-
relation between rosette frequency and hemoglobin, parasite
density, or age in any group. The distribution of rosette fre-
quencies in the three groups is shown in Fig. 1. Rosettes failed
to form with 20 of 54 (37%) of the isolates from mild cases, 11
of 64 (17%) of the isolates from moderate cases, and 4 of 36
(11%) of the isolates from severe cases. In each group there
was a broad scatter of rosette frequencies, with the distribution
being skewed towards lower values. The median rosette fre-
quency of the mild-malaria group (median, 1%; range, 0 to
82%) was lower than those of the moderate-malaria group
(median, 5%; range, 0 to 45%; Mann-Whitney U test, P ,
0.02) and the severe-malaria group (median, 7%; range, 0 to
97%; Mann-Whitney U test, P , 0.003). The difference be-
tween the moderate- and severe-malaria groups was not sta-
tistically significant (Mann-Whitney U test, P , 0.15). Within
the severe-malaria group there were 21 cases of cerebral ma-
laria, 12 cases of prostration, and 3 cases of respiratory distress.
As shown in Fig. 2, there was no difference in rosetting be-
tween the cerebral malarias (median, 6%; range, 0 to 94%) and
the other severe malarias (median, 7%; range, 0 to 97%;
Mann-Whitney U test, P , 0.4).
Twenty isolates (six from severe, eight from moderate, and
six from mild cases) with rosette frequencies of .20% were
tested with autologous plasma at a 1/5 dilution for the presence
of rosette-disrupting antibodies. No rosette disruption was de-
tected in any sample. However, in 8 of 20 isolates (4 from
severe, 2 from moderate, and 2 from mild cases), microagglu-
tination of uninfected and infected erythrocytes was seen.
Plasma samples from the first 150 patients were tested at a
1/10 dilution against a laboratory rosetting clone, R29. Only
three of these plasma samples caused.50% rosette disruption
of R29.
The first 116 isolates were tested for the patient’s ABO
blood group, and the rosette frequencies for each blood group
type are shown in Fig. 3. Isolates from blood group O patients
(n 5 51; median, 2%; range, 0 to 45%) rosetted less well than
isolates from blood group A patients (n 5 30; median, 7%;
range, 0 to 82%; Mann-Whitney U test, P , 0.01) or blood
group AB patients (n 5 16; median, 11%; range, 0 to 94%;
Mann-Whitney U test, P , 0.03). Isolates from blood group B
patients (n 5 19; median, 4%; range, 0 to 27%) also rosetted
less well than isolates from blood group A and AB patients, but
this difference was not statistically significant.
DISCUSSION
In this study we have examined rosetting in a large group of
Kenyan children with mild, moderate, or severe malaria, and
here we show that there is an increase in rosetting with in-
creasing severity of disease. Previous studies in the Gambia
have shown that rosetting is more common in isolates from
children with cerebral malaria than in isolates from children
with uncomplicated malaria (3, 23), and it has been suggested
that rosetting may play a direct role in the pathogenesis of
cerebral malaria by causing obstruction to blood flow in the
microvasculature (11). However, rosette-like aggregates of
FIG. 1. Rosette frequencies of isolates from children with mild, moderate, or
severe malaria.
TABLE 1. Characteristics of patients with mild,
moderate, or severe malaria
Clinical
category of
disease
No. of
cases
Mean age
(SD)
Mean hemo-
globin level
(g/dl) (SD)
Mean parasite
density (SD)a
Mild 54 3 yr 5 mo (27 mo) 8.6 (2.0) 50,476 (40,314)
Moderate 64 1 yr 6 mo (20 mo) 7.0 (2.1) 239,832 (300,352)
Severe 36 2 yr 9 mo (20 mo) 6.9 (2.3) 361,245 (425,986)
a Number of parasites per microliter of blood.
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cells have only rarely been described in postmortem studies on
malaria (7, 19, 20), and it is not even certain that rosettes
actually form in vivo. The present study suggests that rosetting
is not related specifically to cerebral malaria, as there was no
difference in rosetting between the cerebral cases and other
forms of severe malaria. The largest differences seen were
between the mild-malaria group (fever but no other complica-
tions) and both the moderate- and severe-malaria groups. The
median rosette frequency in the severe malaria cases was
higher than that in the moderate cases, but this difference was
not statistically significant. It seems, therefore, that rosetting is
associated with increasing severity of malaria in a general way
rather than with the extreme symptoms of the disease or with
any particular clinical syndrome.
It remains unclear whether rosetting itself is important in the
pathogenesis of malaria or whether its association with disease
reflects some other unidentified causal factor. Ringwald et al.
(21), in a small study of wild isolates fromMadagascar, showed
that rosetting is correlated to the plasma level of tumor necro-
sis factor (TNF), which has itself previously been shown to be
associated with cerebral malaria and poor outcome (12). An-
other study linking rosetting and the level of TNF showed that
in a cloned rosetting line, subcultures selected for high roset-
ting frequency gave significantly higher levels of TNF stimula-
tion than did subcultures with low rosetting frequencies (1).
The relationship between rosetting and TNF stimulation re-
mains unexplained, and their precise roles in malaria patho-
genesis remain uncertain.
If rosetting is directly involved in pathogenesis, it needs to be
explained why some children are infected with parasites which
rosette very well in vitro yet have only mild malaria. One
explanation is that these children might have gone on to de-
velop more severe symptoms if they had not received treat-
ment in time. It is also possible that the size and strength of
rosettes are important in determining clinical outcome, with
large rosettes or those which are particularly resistant to phys-
iological shear forces being more likely to result in microvas-
cular obstruction and disease. Another possibility is that anti-
bodies which inhibit rosetting may modulate clinical outcome.
In previous studies in the Gambia, rosette-disrupting antibod-
ies were commonly found in the plasma of children with un-
complicated malaria but not in the plasma of children with
cerebral malaria (3, 23). In the present study we were unable to
detect autologous rosette-disrupting antibodies in any of 20
high-rosetting-frequency isolates studied (6 from severe, 8
from moderate, and 6 from mild cases of malaria). We did,
however, detect microagglutination of uninfected and infected
erythrocytes in 8 of 20 cases, as described previously (23).
Whether such microagglutination contributes to microvascular
obstruction and disease pathogenesis in vivo is unknown. We
also tested plasmas against a laboratory rosetting clone, R29,
and only rarely detected rosette-disrupting antibodies (3 of 150
samples).
The molecular mechanisms of rosette formation remain un-
known, but there is good evidence that the ABO blood group
affects the ability of uninfected erythrocytes to form rosettes
with parasitized cells. By competition experiments with eryth-
rocytes of different ABO types, it has been shown that blood
group O cells rosette less readily than do cells of other blood
groups (4, 24). The present study examined for the first time
the relationship between blood group and rosetting in a large
group of field isolates and showed that the rosetting frequency
is lower in isolates from blood group O patients than in isolates
from blood group A or AB patients. If rosetting is directly
involved in the pathogenesis of malaria, one might expect that
blood group O children would be relatively protected from
FIG. 2. Rosette frequencies of isolates from children with cerebral malaria or
other forms of severe malaria. FIG. 3. Rosette frequencies of isolates by patient ABO blood group.
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severe disease. In the Gambia, an association between blood
group O and protection from cerebral malaria has been dem-
onstrated (7a, 8), but in Kenya, where the present study was
undertaken, blood groups O and A seem to confer some pro-
tection (13a); however, in both cases the effects are small.
There is now mounting evidence that rosetting is related to
the severity of clinical disease in malaria, but it remains unclear
whether rosetting itself is important in pathogenesis or is sim-
ply a marker for some other factor which mediates the disease
process. It is possible that rosetting is a manifestation of cy-
toadherence to an as-yet-uncharacterized endothelial receptor
which also happens to be expressed on erythrocytes, but this
remains speculative until the precise receptor-ligand interac-
tions which mediate rosette formation have been identified.
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